PHARMA 4.0

Sales & Marketing

With healthcare marketing becoming more digital than ever, artificial intelligence (AI) for marketers has ceased to be merely a buzzword.

Partner Content

Partner Content

Parallel Trade Conference

News

Biofinancing values have tailed off a bit after a strong start to 2026, but March has seen $50m+ rounds for R1, Crossbow, Excalipoint, and Prolium.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.